Your white blood cells could help cure cancer – Here's how to donate

NCT ID NCT02821806

Recruiting now Knowledge-focused Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study collects white blood cells from healthy volunteers to help researchers develop new immune-based cancer treatments. Participants undergo a 4-6 hour procedure called leukapheresis, where a machine separates white cells from the rest of the blood. Donors must be 18 or older, meet health criteria, and can donate every 21 days. The cells are used in the lab to improve T-cell therapies that may one day fight tumors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help scientists develop better T-cell therapies that use a patient's own immune system to fight cancer.
What could go wrong: This is a sample-collection study, not a treatment trial. The cells are used for lab research, so there is no direct benefit to participants or guarantee that new therapies will result.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEER

Contacts and locations

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.